Japanese Simple Chinese Traditional Chinese Korean 

Conference Menu

Current Event

Short Course
Day 1
Day 2
Day 3
PDF Download
Hotel & Travel 
Sponsor & Exhibits
Press Pass 
Request Brochure 



Reaction Biology 




Science AAAS 


The Scientist 

Markets and Markets logo 



Reports and Reports 

Next-Gen Kinase Inhibitors

Conference Proceeding CD Now Available
  • Speaker Presentations
  • Poster Abstracts
  • and More!

Final Weeks to Register! 


ArrowDesigning, Screening and Assessing Selectivity 

ArrowIdentifying and Assaying Allosteric Kinase Inhibitors 

ArrowCovalent Inhibition 

ArrowKinases for CNS Indications – An Exciting Challenge 

ArrowInflammation& Autoimmune – Leading Programs 

ArrowKinases in Oncology – PI3, mTOR, cMet  & More 

ArrowNovel Kinase Targets in Hot Pursuit 

ArrowScreening & Monitoring DMPK and Tox 

ArrowAdvances in Computational Methods 

ArrowResistance – Future Challenges 

Click here for the final agenda 

Distinguished Faculty 

Mark Ashwell, ArQule Inc
James Blake, Array BioPharma, Inc.
Peter Brandt, Beactica AB
Stephen K. Burley, Eli Lilly & Company
Dirksen Bussiere, Novartis Vaccines & Diagnostics Inc.
Josette Carnahan, Amgen
Kenneth Comess, Abbott Laboratories
Jean Cui, Pfizer, Inc.
Greg Cuny, Brigham & Women’s Hospital
David C. Dalgarno, ARIAD Pharmaceuticals Inc.
David H. Drewry, GlaxoSmithKline
Isabelle Dussault, Amgen
Doriano M. Fabbro, Novartis Institutes for BioMedical Research
Jordan S. Fridman, Incyte Corp.
Daniel Goldberg, Karos Pharmaceuticals, Inc.
Andrew C. Good, Genzyme Corp
John D. Haley, OSI Pharmaceuticals
Stephanos Ioannidis, AstraZeneca
Ronald Knegtel, Vertex Pharmaceuticals (Europe) Ltd.
Ravi G. Kurumbail, Pfizer, Inc.
Chris Liang, Xcovery, LLC
Carol MacKintosh, University of Dundee
Henrik Mobitz, Novartis
Yibing Shan, D. E. Shaw Research
Juswinder Singh, Avila Therapeutics, Inc.
Rajinder Singh, Rigel Pharmaceuticals Inc.
Kent Stewart, Abbott
Eli Wallace, Array BioPharma
Neil Wishart, Abbott
Paul Yu, Massachusetts General Hospital
Donald Zack, Johns Hopkins University School of Medicine

Specialized Panels:

I. Next Generation Kinases –
Selectivity What Now?

II. Structure-Based Kinase
Inhibitor Design

Presented by hand-selected panelists who have contributed more than a decade
of research to the kinase field!


June 6th Half Day
Pre-Conference Short Course:

The Art and Science of Kinases -
What you Need to Know

Kent Stewart, Ph.D. Research Fellow, Abbott 

Co-Located with:11th Annual Structure-Based Drug Design Conference
June 8-10


By Series:
By Region: